A detailed history of American Century Companies Inc transactions in Incyte Corp stock. As of the latest transaction made, American Century Companies Inc holds 66,279 shares of INCY stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,279
Previous 77,489 14.47%
Holding current value
$4.73 Million
Previous $5.12 Million 10.64%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$65.08 - $83.38 $729,546 - $934,689
-11,210 Reduced 14.47%
66,279 $4.58 Million
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $9.35 Million - $11.2 Million
-163,114 Reduced 67.79%
77,489 $5.12 Million
Q2 2024

Aug 07, 2024

SELL
$51.18 - $63.75 $258,510 - $322,001
-5,051 Reduced 2.06%
240,603 $14.6 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $896,600 - $1.06 Million
-15,855 Reduced 6.06%
245,654 $14 Million
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $13.6 Million - $16.8 Million
261,509 New
261,509 $16.4 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $2.94 Million - $3.36 Million
50,930 Added 25.74%
248,771 $14.4 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $21.8 Million - $27 Million
-358,071 Reduced 64.41%
197,841 $12.3 Million
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $27 Million - $33 Million
383,789 Added 222.97%
555,912 $40.2 Million
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $10 Million - $12.5 Million
149,129 Added 648.56%
172,123 $13.8 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $7.14 Million - $8.94 Million
-107,947 Reduced 82.44%
22,994 $1.53 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $8.07 Million - $10.1 Million
121,934 Added 1353.77%
130,941 $9.95 Million
Q1 2022

May 11, 2022

SELL
$66.02 - $79.71 $273,983 - $330,796
-4,150 Reduced 31.54%
9,007 $715,000
Q4 2021

Feb 07, 2022

BUY
$63.34 - $74.11 $477,773 - $559,011
7,543 Added 134.36%
13,157 $966,000
Q3 2021

Nov 10, 2021

SELL
$68.67 - $84.02 $14.2 Million - $17.3 Million
-206,321 Reduced 97.35%
5,614 $386,000
Q2 2021

Aug 05, 2021

BUY
$79.87 - $87.53 $68,847 - $75,450
862 Added 0.41%
211,935 $17.8 Million
Q1 2021

May 14, 2021

BUY
$76.02 - $100.5 $15.9 Million - $21 Million
208,637 Added 8564.74%
211,073 $17.2 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $18.9 Million - $22.8 Million
-233,819 Reduced 98.97%
2,436 $212,000
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $9.35 Million - $12.1 Million
109,921 Added 87.01%
236,255 $21.2 Million
Q2 2020

Aug 13, 2020

SELL
$74.18 - $108.93 $7.45 Million - $10.9 Million
-100,401 Reduced 44.28%
126,334 $13.1 Million
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $12 Million - $16.3 Million
-189,476 Reduced 45.52%
226,735 $16.6 Million
Q4 2019

Feb 12, 2020

BUY
$73.04 - $95.72 $2.58 Million - $3.38 Million
35,287 Added 9.26%
416,211 $36.3 Million
Q3 2019

Nov 13, 2019

BUY
$72.82 - $86.52 $10.8 Million - $12.9 Million
148,938 Added 64.2%
380,924 $28.3 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $7.21 Million - $8.7 Million
98,035 Added 73.19%
231,986 $19.7 Million
Q1 2019

May 14, 2019

SELL
$63.56 - $88.17 $5.65 Million - $7.83 Million
-88,859 Reduced 39.88%
133,951 $0
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $4.29 Million - $5.13 Million
73,294 Added 49.02%
222,810 $14.2 Million
Q3 2018

Nov 02, 2018

BUY
$61.75 - $74.23 $9.23 Million - $11.1 Million
149,516 New
149,516 $10.3 Million
Q2 2018

Aug 08, 2018

SELL
$60.85 - $83.98 $22.9 Million - $31.6 Million
-376,243 Closed
0 $0
Q1 2018

May 03, 2018

SELL
$83.06 - $100.98 $22.8 Million - $27.7 Million
-274,154 Reduced 42.15%
376,243 $31.4 Million
Q4 2017

Feb 02, 2018

SELL
$93.56 - $116.6 $36.7 Million - $45.8 Million
-392,482 Reduced 37.63%
650,397 $61.6 Million
Q3 2017

Nov 01, 2017

BUY
$109.15 - $138.27 $114 Million - $144 Million
1,042,879
1,042,879 $122 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.